Total Payments
$68,079
2024 Payments
$610.26
Companies
28
Transactions
622
Medicare Patients
5,147
Medicare Billing
$571,481
Payment Breakdown by Category
Other$52,971 (77.8%)
Food & Beverage$10,929 (16.1%)
Consulting$3,300 (4.8%)
Travel$711.72 (1.0%)
Education$168.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,600 | 43 | 77.3% |
| Food and Beverage | $10,929 | 563 | 16.1% |
| Consulting Fee | $3,300 | 2 | 4.8% |
| Travel and Lodging | $711.72 | 3 | 1.0% |
| Entertainment | $370.63 | 9 | 0.5% |
| Education | $168.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $51,566 | 92 | $0 (2020) |
| Romark Laboratories, LC | $10,581 | 146 | $0 (2020) |
| ABBVIE INC. | $2,111 | 164 | $0 (2024) |
| QOL Medical, LLC | $799.36 | 52 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $588.95 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $587.65 | 32 | $0 (2023) |
| Covidien LP | $301.90 | 9 | $0 (2019) |
| INTERCEPT PHARMACEUTICALS, INC. | $178.48 | 10 | $0 (2022) |
| Gilead Sciences, Inc. | $177.49 | 8 | $0 (2023) |
| PFIZER INC. | $171.01 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $610.26 | 32 | ABBVIE INC. ($215.09) |
| 2023 | $1,107 | 62 | QOL Medical, LLC ($410.22) |
| 2022 | $918.92 | 67 | ABBVIE INC. ($373.97) |
| 2021 | $803.46 | 57 | AbbVie Inc. ($293.00) |
| 2020 | $1,257 | 64 | Romark Laboratories, LC ($751.72) |
| 2019 | $2,648 | 85 | Romark Laboratories, LC ($1,957) |
| 2018 | $19,401 | 129 | Allergan Inc. ($14,787) |
| 2017 | $41,334 | 126 | Allergan Inc. ($36,705) |
All Payment Transactions
622 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.42 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/12/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $89.62 | General |
| Category: Gastrointestinal AI | ||||||
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Gastroenterology | ||||||
| 09/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: GI | ||||||
| 09/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $4.75 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $1.67 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $7.63 | General |
| Category: THERAPY FOR CSID | ||||||
| 05/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $7.35 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: General - EndoChoice_ENDO | ||||||
| 03/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,070 | 1,205 | $950,179 | $121,789 |
| 2022 | 15 | 1,198 | 1,361 | $1.1M | $135,693 |
| 2021 | 15 | 1,304 | 1,502 | $1.0M | $143,751 |
| 2020 | 18 | 1,575 | 1,924 | $1.2M | $170,247 |
Total Patients
5,147
Total Services
5,992
Medicare Billing
$571,481
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 128 | 129 | $176,859 | $24,412 | 13.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 75 | 77 | $81,158 | $13,111 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 196 | $36,625 | $11,830 | 32.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 76 | 86 | $31,906 | $8,297 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 89 | $24,297 | $7,791 | 32.1% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 13 | 13 | $31,681 | $7,034 | 22.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 81 | 89 | $237,808 | $6,961 | 2.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 58 | 58 | $70,296 | $6,109 | 8.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 55 | 56 | $57,008 | $5,843 | 10.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 28 | 28 | $29,512 | $4,964 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $16,458 | $4,963 | 30.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 70 | 126 | $13,986 | $4,723 | 33.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 66 | 67 | $54,337 | $4,308 | 7.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $49,488 | $3,047 | 6.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $11,275 | $2,933 | 26.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 36 | $6,984 | $2,045 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $8,720 | $2,022 | 23.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 11 | 11 | $11,781 | $1,397 | 11.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 170 | 171 | $234,441 | $30,196 | 12.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 211 | 276 | $51,067 | $16,665 | 32.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 98 | 98 | $103,292 | $16,425 | 15.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 81 | 83 | $30,793 | $8,447 | 27.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 92 | 100 | $267,200 | $8,299 | 3.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 90 | $24,570 | $7,962 | 32.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 85 | 85 | $103,020 | $7,948 | 7.7% |
About Dr. Joseph Hathaway, MD
Dr. Joseph Hathaway, MD is a Gastroenterology healthcare provider based in Statesboro, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760461925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Hathaway, MD has received a total of $68,079 in payments from pharmaceutical and medical device companies, with $610.26 received in 2024. These payments were reported across 622 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,600).
As a Medicare-enrolled provider, Hathaway has provided services to 5,147 Medicare beneficiaries, totaling 5,992 services with total Medicare billing of $571,481. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Statesboro, GA
- Active Since 01/15/2006
- Last Updated 10/20/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760461925
Products in Payments
- LINZESS (Drug) $50,387
- Alinia Tablets 500mg 30 count bottle (Drug) $7,872
- Alinia (Drug) $1,957
- VIBERZI (Drug) $1,403
- ALINIA (Drug) $751.72
- STELARA (Biological) $552.88
- Humira (Biological) $473.35
- Sucraid (Drug) $410.22
- SUCRAID (Drug) $389.14
- HUMIRA (Biological) $374.08
- XIFAXAN (Drug) $370.44
- RINVOQ (Biological) $366.42
- SKYRIZI (Biological) $234.09
- CREON (Drug) $225.65
- Barrx (Device) $186.84
- XELJANZ (Drug) $171.01
- OCALIVA (Drug) $160.54
- TRULANCE (Drug) $150.88
- PREPOPIK (Drug) $95.41
- ENTYVIO (Biological) $92.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.